Health Canada Approves Drug to Slow Alzheimer’s Disease
On 25 October 2025, Health Canada approved lecanemab (brand name Leqembi) for use in Canada. This is the first medication in more than a decade—and the first in Canada with a mechanism of action targeting the underlying biology of Alzheimer’s disease. Lecanemab is indicated for people diagnosed with early-stage Alzheimer’s disease or mild cognitive impairment […]

Exploring Health and Wealth on Health Conceptual Solutions
Bobby Buck introduced Focusivity to the Cannaglobe business during a conversation highlighting its innovative approach to health and wellness. As a leader in *Out the Box Economics*, Bobby shared his personal experience with the virtual dispensary model, emphasizing its simplicity and the life-enhancing benefits of the products. His passion for Cannaglobe’s mission to revolutionize the cannabis industry resonated with Focusivity, inspiring her to explore the opportunity and join the movement to promote health, wellness, and financial empowerment through Cannaglobe.